Delivery Order 75N95022D00005-75N95025F00001
Award Date
2/15/25
Potential Completion Date
4/25/25
Potential Value
$595K
Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
San Diego, CA 92126, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Walsh Healy Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
<p>The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $518,493 delivery order contract to Polypeptide Laboratories San Diego, LLC doing business as Polypeptide Labs. The contract is for the synthesis and distribution of opioid and related peptides, with a period of performance from February 15, 2023 through February 14, 2024. The place of performance is San Diego, California. The pricing structure is cost plus fixed fee.</p>
Polypeptide Laboratories San Diego, LLC, doing business as Polypeptide Labs, has been awarded a firm fixed price delivery order against its indefinite delivery contract with the National Institutes of Health's National Institute on Drug Abuse. The $598,190 delivery order is for the synthesis and distribution of opioid and related peptides over the one year period of performance from February 15, 2024 through February 14, 2025. The underlying indefinite delivery contract, awarded in 2022...
This federal contract award, valued at $200,532.62, was issued by the National Institute on Drug Abuse (NIDA), a civilian agency within the National Institutes of Health (NIH), to Polypeptide Laboratories San Diego, LLC, a for-profit biotechnology and pharmaceutical research company. The contract is for the synthesis and distribution of opioid and related peptides, which supports critical biomedical research initiatives. This award is associated with a larger $2,781,317 Indefinite Delivery...
This is a firm fixed-price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency of the U.S. government, to Polypeptide Laboratories San Diego, LLC (doing business as Polypeptide Labs), a specialized manufacturer of peptides and related compounds. The contract, valued at $62,100.10, is for the storage and stability study of drug substances and products. The contract does not have a set-aside designation and is scheduled for...
The National Institute of Child Health and Human Development (NICHD), part of the National Institutes of Health (NIH), has awarded a $17,950 firm fixed-price purchase order to Polypeptide Laboratories San Diego, LLC (Polypeptide Labs) for a storage and stability study of drug substances and products. This contract, which has an ultimate completion date of July 31, 2025, does not have a set-aside designation.
Polypeptide Labs is a specialized manufacturer of peptides and related compounds,...
The Department of Health and Human Services National Institutes of Health National Institute of Child Health and Human Development awarded a $23,000 firm fixed price purchase order to Polypeptide Laboratories San Diego, LLC for peptide synthesis facility services. Specifically, Polypeptide Labs will provide storage and stability studies of drug substances and products in support of the agency's biomedical research efforts. Performance will take place in San Diego, California over a 10-month...
<p>The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $24,900 firm fixed price purchase order contract to Pelago Bioscience AB, a for-profit limited liability company. The contract is for the development of a new assay to test compounds of interest. The period of performance runs from the award date of September 9, 2024 through September 8, 2025. This contract award does not have a set-aside designation.</p>
This is a firm fixed-price delivery order issued by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse (NIDA) to Eurofins Panlabs, Inc., a foreign-owned for-profit contract research organization. The $359,131 order is for a 1-year period of performance from September 30, 2020 to September 29, 2021 under the NIDA N01DA-18-8937 contract vehicle. The work involves receptor binding and predictive toxicology services to support NIDA's drug...
This contract awarded by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse (HHS-NIH-NIDA) to Research Triangle Institute - doing business as R T I International is for the synthesis and distribution of drugs of abuse and related compounds from June 9, 2023 to June 8, 2024 under Task Order 75N95023F00001 (TO4) of major program N01DA-22-8944. The contract type is a delivery order with a place of performance in Research Triangle Park,...
This is a $96,900.00 firm-fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Edelris, a for-profit manufacturer, for a chemical library of 2,550 small molecule compounds distributed across specified chemical scaffolds. The contract has an ultimate completion date of October 15, 2019. The requirement was originally posted as an open solicitation and there was no set-aside designation. The chemical library will be used by NIDA's...